Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I/II Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer

Trial Profile

Phase I/II Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer

Status: Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 07 Feb 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Delolimogene mupadenorepvec (Primary)
  • Indications Biliary cancer; Carcinoma; Colorectal cancer; Fallopian tube cancer; Ovarian cancer; Pancreatic cancer; Peritoneal cancer
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Sponsors Lokon Pharma
  • Most Recent Events

    • 31 Jan 2024 Planned End Date changed from 1 Dec 2024 to 22 Aug 2024.
    • 20 Oct 2023 This trial has been completed (End Date: 22 Aug 2023), according to European Clinical Trials Database record.
    • 19 Apr 2023 Results (n=27) presented at the 114th Annual Meeting of the American Association for Cancer Research
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top